Richard S Hotchkiss MD
Critical Care Medicine
Professor, Anesthesiology, Washington University in St. Louis School
Join to View Full Profile
1 Barnes Jewish Hospital PlzDept AnesthesiologySaint Louis, MO 63110
Phone+1 800-862-9980
Fax+1 314-362-1185
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Hotchkiss, MD is a board certified anesthesiologist in Saint Louis, Missouri. He is currently licensed to practice medicine in Missouri and Georgia. He is a Professor at Washington University in St. Louis School.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Anesthesiology, 1981 - 1984
Emory University School of MedicineResidency, Internal Medicine, 1976 - 1980
University of Virginia School of MedicineClass of 1976- Mass General Brigham/Massachusetts General HospitalFellowship, Critical Care Medicine (Anesthesiology)
Certifications & Licensure
MO State Medical License 1987 - 2026
GA State Medical License 1977 - 1987
American Board of Anesthesiology Anesthesiology- American Board of Anesthesiology Critical Care Medicine
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19.Manu Shankar-Hari, Bruno Francois, Kenneth E Remy, Cristina Gutierrez, Stephen Pastores
JCI Insight. 2025-02-04 - 2 citationsRegulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization.Sun Ryu, Jintao Zhang, Roli Simoes, Xuemei Liu, Zhaohua Guo
The Journal of Headache and Pain. 2024-11-11 - Development and optimization of a diluted whole blood ELISpot assay to test immune function.Ricardo F Ungaro, Julie Xu, Tamara A Kucaba, Mahil Rao, Christian B Bergmann
Journal of Immunological Methods. 2024-10-01
Press Mentions
HMN 2025: How IL-7 Remedy Reveals Promise in Decreasing Deadly Secondary Infections in Critically in Poor Health COVID-19 SufferersApril 2nd, 2025- IL-7 Treatment Shows Promise in Reducing Lethal Secondary Infections in Critically Ill COVID-19 PatientsApril 1st, 2025
- Immune Booster Reduces Secondary Infections in COVID-19 PatientsApril 1st, 2025
- Join now to see all
Grant Support
- Enhancing Innate and Adaptive Immunity to Improve Sepsis SurvivalWASHINGTON UNIVERSITY2018–2028
